marketnews

Expert Economist Bill Gross Predicts US Recession in Q4: Why Higher for Longer is No Longer the Mantra

Bill Gross’ Economic Predictions: What to Expect The Retired Bond King’s Insights First Bill Ackman, now Bill Gross. The retired bond king has recently made some bold predictions about the state of the U.S. economy, and investors are taking note. Gross, known for his successful career in the world of fixed-income investments, has a reputation…

Read More

Unlocking the Markets: A Weekly Review of DAX 40 and Dow Jones – October 23-27 Analysis

Market movers This week major US stock indexes experienced a significant decline, following Federal Reserve Chairman Jerome Powell’s speech regarding sticky inflation and the likelihood of an unchanged interest rate at the November meeting. Treasury yields have once again breached the 5% threshold, a level not seen since 2007. In the meanwhile, geopolitical tensions are…

Read More

Uncovering the Truth: President Trump and Australian Billionaire Anthony Pratt Caught on Tape

New Revelations about Anthony Pratt’s Comments on Trump Post-Presidency Introduction New court documents reviewed by the New York Times have revealed shocking details about Anthony Pratt, Donald Trump’s Australian friend. Pratt reportedly shared insider information about life at Mar-a-Lago post-presidency, including his true feelings about Trump. Pratt’s Betrayal According to the documents, Pratt disclosed confidential…

Read More

Revolution Medicines Unveils Promising Clinical Results and Safety Data from Phase 1/1b Trial of RMC-6236

Investor Webcast to be held Sunday, October 22 at 12:30 p.m. Eastern Time REDWOOD CITY, Calif., Oct. 22, 2023 (GLOBE NEWSWIRE) Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, today announced promising anti-tumor and safety data for RMC-6236, its RASMULTI(ON) Inhibitor, in patients with previously treated non-small cell…

Read More